Molecular and Genetic Profiling for Precision Medicines in Pulmonary Arterial Hypertension
Pulmonary arterial hypertension (PAH) is a rare and chronic lung disease characterized by progressive occlusion of the small pulmonary arteries, which is associated with structural and functional alteration of the smooth muscle cells and endothelial cells within the pulmonary vasculature. Excessive...
Main Authors: | Shahood Fazal, Malik Bisserier, Lahouaria Hadri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-03-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/3/638 |
Similar Items
-
Switch-Independent 3A: An Epigenetic Regulator in Cancer with New Implications for Pulmonary Arterial Hypertension
by: Katherine Jankowski, et al.
Published: (2023-12-01) -
Pulmonary Arterial Hypertension: Emerging Principles of Precision Medicine across Basic Science to Clinical Practice
by: Neil J. Kelly, et al.
Published: (2022-11-01) -
Computational Simulator Models and Invasive Hemodynamic Monitoring as Tools for Precision Medicine in Pulmonary Arterial Hypertension
by: Giovanna Manzi, et al.
Published: (2021-12-01) -
FROM PERSONALIZED TO PRECISION MEDICINE
by: K. V. Raskina, et al.
Published: (2017-03-01) -
Precision medicine advances in idiopathic pulmonary fibrosis
by: Theodoros Karampitsakos, et al.
Published: (2023-09-01)